TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Company Overview - TELA Bio, Inc. is a commercial-stage medical technology company focused on innovative soft-tissue reconstruction solutions that optimize clinical outcomes by preserving and restoring the patient's own anatomy [3] Recent Developments - The Compensation Committee of TELA Bio's Board of Directors approved inducement grants of restricted stock units covering 16,000 shares to nine newly-hired employees, with a grant date of August 6, 2024 [1] - The restricted stock units will vest in equal annual installments over four years, contingent on each individual's continued service with TELA Bio [2]